TITLE

LINFOPENIA T CD4 NO LÚPUS ERITEMATOSO SISTÉMICO

AUTHOR(S)
Ferreira, Sofia; Vasconcelos, JúIia; Marinho, António; Farinha, Fátima; AImeida, Isabel; Correia, João; Barbosa, Paulo; Mendonça, Teresa; VasconceIos, Carlos
PUB. DATE
April 2009
SOURCE
Acta Reumatológica Portuguesa;2009, Vol. 34 Issue 2, p200
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Systemic Lupus Erythematosus (SLE) is an inflammatory chronic disease characterized by the presence of autoantibodies, immunocomplex production and organ injury. Several alterations of the immune system have been described, namely of CD4 T cells, with particular focus on regulatory subgroup. Objective: Quantify peripheral CD4 T cells in a population of patients with SLE and correlate it with lupus activity, affected organs, therapeutics and infections. Methods: Retrospective study involving all SLE patients seen in the clinical immunology outpatient clinic of the Hospital Geral Santo Antonio, Porto that has done some peripheral blood flow cytometry study. Results: Twenty-nine patients have been evaluated, 16 were taking glucocorticoids and six immunossupressors. The mean SLEDAI at the study time was nine and the ECLAM was three. Thirty-one percent of the patients had leukopenia, 76% lymphocytopenia arid the same number CD4 depletion. Fifty-five percent of the patients had CD4 levels lower than 500/mm3, 31% lower than 200/mm3. All patients with SLEDM ⩾20 and ECLAM ⩾4 had CD4 counts inferior to 500/mm3 and all patients with inactive disease had CD4 superior to 500/mm3. There have been three opportunistic infections: cryptococcal meningitis, pulmonary aspergilosis, Pneumocystis jirovecii pneumonia, all in patients with CD4 counts lower than 500/mm3. Conclusion: Decreased CD4 T cells counts have been very common in this study population. There is an inverse relation between CD4 cells counts and disease activity. Opportunistic infections occurred in patients with severe CD4 depletion.
ACCESSION #
42430646

 

Related Articles

  • Th22, but not Th17 Might be a Good Index to Predict the Tissue Involvement of Systemic Lupus Erythematosus. Yang, Xu-yan; Wang, Hui-ying; Zhao, Xiao-ying; Wang, Li-juan; Lv, Qing-hua; Wang, Qing-qing // Journal of Clinical Immunology;May2013, Vol. 33 Issue 4, p767 

    Purpose: T-helper (Th) cells abnormalities are considered to be associated with the pathogenesis of Systemic lupus erythematosus (SLE). Recently, The Th22 cells have been identified and implicated in the pathogenesis of autoimmune diseases such as Rheumatoid arthritis (RA), although therir role...

  • Expression of Ets-1 and FOXP3 mRNA in CD4CD25 T regulatory cells from patients with systemic lupus erythematosus. Xiang, Nan; Li, Xiang-Pei; Li, Xiao-Mei; Wang, Guo-Sheng; Tao, Jin-Hui; Pan, Hai-Feng; Fang, Xuan; Ma, Qian; Yu, Ning // Clinical & Experimental Medicine;Nov2014, Vol. 14 Issue 4, p375 

    Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with complex genetic predisposing factors involved. Ets-1 transcription factor plays an important role in the suppressive activity of CD4CD25 Treg cells and stable expression of FOXP3. To find its potential role in the...

  • CD4 TCRBV CDR3 Analysis in prevalent SLE Cases from two ethnic Groups. Fraser, P.A.A.; Lu, L-Y.; DeCeulaer, K.; Schur, P.H.; Fici, D.; Awdeh, Z.; Ding, W-Z.; Levitan, E.; Lew, R.; Uko, G.; Gonzalez, C. // Lupus;1999, Vol. 8 Issue 4, p311 

    We examined CD4+ T cell TCRBV-CDR3 transcripts from 19 lupus patients and 16 controls to test the hypothesis that CD4+ TCRBV-CDR3 expression in SLE differs from normals. Within the disease group we also performed exploratory analyses to determine the association between risk of oligoclonality...

  • Circulating TFH Subset Distribution Is Strongly Affected in Lupus Patients with an Active Disease. Le Coz, Carole; Joublin, Aurélie; Pasquali, Jean-Louis; Korganow, Anne-Sophie; Dumortier, Hélène; Monneaux, Fanny // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Follicular helper T cells (TFH) represent a distinct subset of CD4+ T cells specialized in providing help to B lymphocytes, which may play a central role in autoimmune diseases having a major B cell component such as systemic lupus erythematosus. Recently, TFH subsets that share common...

  • The Janus Face of CD4+CD25+ Regulatory T Cells in Cancer and Autoimmunity. Danese, S.; Rutella, S. // Current Medicinal Chemistry;2007, Vol. 14 Issue 6, p649 

    Regulatory T cells (Treg) encompass a heterogeneous family of T cells implicated in maintenance of tolerance to self antigens. Treg cells might be qualitatively and/or quantitatively deficient in human autoimmune diseases, including multiple sclerosis, graft versus host disease, systemic lupus...

  • Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus. Martínez-Ramos, R; García-Lozano, J-R; Lucena, J-M; Castillo-Palma, M-J; García-Hernández, F; Rodríguez, M-C; Núñez-Roldán, A; González-Escribano, M-F // Lupus;Apr2014, Vol. 23 Issue 4, p353 

    The article presents a study which examined the pattern of expression in microRNAs in CD19+ and CD4+ cells from asymptomatic patients with systemic lupus erythematosus (SLE). The researchers performed a screening of the expression of 377 miRNAs in human CD4+ and CD19+ cells isolated from the...

  • Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Piotrowski, Piotr; Burzyński, Michał; Lianeri, Margarita; Mostowska, Magdalena; Wudarski, Mariusz; Chwalińska-Sadowska, Hanna; Jagodziński, Pawel E. // Folia Histochemica et Cytobiologica;2007, Vol. 45 Issue 4, p339 

    The glucocorticoid receptor (GR) occurs mainly in two alternative splice variants encoding GRα and GRβ. The GRβ variant does not contain a GC binding domain and cannot mediate anti-inflammatory GC effects. Peripheral blood mononuclear cells (PBMCs) were isolated from venous whole blood...

  • Effects of anti-CD4 antibodies on the release of IL-6 and TNF-a in whole blood samples from patients with systemic lupus erythematosus. Brink, I.; Thiele, B.; Burmester, G-R.; Trebeljahr, G.; Emmrich, F.; Hiepe, F. // Lupus;1999, Vol. 8 Issue 9, p723 

    Anti-CD4 antibodies have been recently introduced into the therapy of various autoimmune diseases, among them systemic lupus erythematosus (SLE). Their modes of action are not yet fully understood. Interference with cytokine release may be one possible mechanism. Therefore, the effects of...

  • A correlation study on the effects of DNMT1 on methylation levels in CD4+ T cells of SLE patients. Jun Liang; Xiao-Hua Zhu; Hai-Hong Qin; Jin-Ran Lin; Duo-Qin Wang; Lan Huang; Xiao-Qun Luo; Jin-Hua Xu // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 10, p19701 

    Objective: To study the effect of DNMT1 on CD4+ T cells in the peripheral blood of systemic lupus erythematosus (SLE) patients. Methods: To investigate the differential expression of DNMT1 in CD4+ T cells of SLE patients and healthy individuals, a DNMT1 lentiviral plasmid (pLenti6.3/V5-DNMT1)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics